Aranthan S. Jones II Net Worth & Insider Trades
Aranthan S. Jones II - Chief Corp. Affairs Officer, Vanda Pharmaceuticals Inc
What is Aranthan S. Jones II's Net Worth?
The current estimated net worth of Vanda Pharmaceuticals Inc's Chief Corp. Affairs Officer, Aranthan S. Jones II, is estimated to be about $2M . Aranthan S. Jones II owns about 81,980 units of Vanda Pharmaceuticals Inc common stock. In the last year at Vanda Pharmaceuticals Inc, Aranthan S. Jones II has sold an estimated value of $1.43M worth.
What is Aranthan S. Jones II's Past Insider Trading?
Aranthan S. Jones II's largest purchase order was 48,299 units , worth over $276.06K on February 26, 2021. Aranthan S. Jones II's largest sale order was 22,986 units , worth over $460.03K on February 26, 2021. In total, Aranthan S. Jones II has made about 8 transactions over a year of their time at Vanda Pharmaceuticals Inc. Aranthan S. Jones II usually trades in March, July and February, with the busiest year in 2021. The most recent transaction was a sale order of 16,824 units , worth over $277.39K on September 17, 2021.
Aranthan S. Jones II
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What was Aranthan S. Jones II's Salary in 2020?
As Chief Corp. Affairs Officer of Vanda Pharmaceuticals Inc, Aranthan S. Jones II has a total base salary of $406,104 . Aranthan S. Jones II received compensation valued at about $1,378,317 in 2020 after becoming Chief Corp. Affairs Officer. The vast majority of their compensation came in the form of stock awards of $339,600 , option awards of $397,915 , other earnings, plans or compensations of $201,021 , and other compensation of $33,677 .
What is Aranthan S. Jones II's' Mailing Address?
- Mailing address is 2200 Pennsylvania Ave Nw Suite 300e Washington Dc DC 20037 DC
Vanda Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
Mihael H. Polymeropoulos, M.D. | 2020 | $746,235 | - | $679,200 | $795,830 | $656,687 | $35,468 | $2,913,420 |
Mihael H. Polymeropoulos, M.D. | 2019 | $721,000 | - | $1,237,200 | $1,610,154 | $675,000 | $34,783 | $4,278,137 |
Mihael H. Polymeropoulos, M.D. | 2018 | $700,000 | - | $1,131,000 | $1,456,406 | $700,000 | $37,322 | $4,024,728 |
James P. Kelly | 2020 | $124,057 | - | - | - | - | $16,217 | $140,274 |
James P. Kelly | 2019 | $493,370 | - | $618,600 | $805,077 | $288,622 | $42,741 | $2,248,410 |
James P. Kelly | 2018 | $479,000 | - | $754,000 | $832,232 | $299,375 | $36,778 | $2,401,385 |
Kevin Moran | 2020 | $324,693 | - | $331,101 | $427,779 | $200,000 | $36,126 | $1,319,699 |
Joakim Wijkstrom | 2020 | $506,422 | - | $339,600 | $397,915 | $250,679 | $29,269 | $1,523,885 |
Aranthan "AJ" Jones II | 2020 | $406,104 | - | $339,600 | $397,915 | $201,021 | $33,677 | $1,378,317 |
Timothy Williams | 2020 | $400,000 | - | $339,600 | $397,915 | $200,000 | $41,546 | $1,379,061 |
Timothy Williams | 2019 | $379,315 | - | $618,600 | $805,077 | $177,520 | $42,342 | $2,022,854 |
Timothy Williams | 2018 | $144,886 | $40,000 | $643,500 | $1,086,894 | $71,918 | $15,658 | $2,002,856 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1347178/000134717821000008/vnda-20210422xdef14a.htm
What are Vanda Pharmaceuticals Inc's Past Insider Trades?
Vanda Pharmaceuticals Inc's most recent insider trade came on March 6, 2023 by Timothy Williams who sold 16,738 units worth $104.57K . In the last 17 years, insiders at Vanda Pharmaceuticals Inc have sold an estimated value of $297.86M and bought an estimated value of $28.74M worth of shares. Insider trading is most common in June, with the busiest year in 2006. The most active traders at the company are Mihael Polymeropoulos, President and CEO, James P. Kelly, EVP & Chief Financial Officer, and Richard W Dugan, Director .
Vanda Pharmaceuticals Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |